RASTETTER WILLIAM H
Reporting owner on Forms 3, 4 and 5, CIK 1205903.
RASTETTER WILLIAM H reported on 2 issuers in 4 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| DARE · Dare Bioscience, Inc.CIK 1401914 | director | 1 | 2026-11-20 |
| Iambic Therapeutics, Inc. CIK 1997038 | director, other | 3 | 2026-10-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| DARE · Dare Bioscience, Inc.Common stock | 2026-11-19 | S sold | -859 | $0.445 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Common Stock | 2026-10-16 | C converted | +192,579 | 192,579 | Form 4 | |
| Iambic Therapeutics, Inc. Common Stock | 2026-10-16 | C converted | +8,341 | 200,920 | Form 4 | |
| Iambic Therapeutics, Inc. Series B Convertible Preferred Stock, derivative | 2026-10-16 | C converted | -76,801 | $0 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Series B-2 Convertible Preferred Stock, derivative | 2026-10-16 | C converted | -64,001 | $0 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Series B-3 Convertible Preferred Stock, derivative | 2026-10-16 | C converted | -36,805 | $0 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Series B-4 Convertible Preferred Stock, derivative | 2026-10-16 | C converted | -14,972 | $0 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Convertible Promissory Notes, derivative | 2026-10-16 | C converted | -8,341 | $0 | 0 | Form 4 |
| Iambic Therapeutics, Inc. Stock Option (right to buy), derivative | 2026-10-14 | A granted | +40,600 | $0 | 40,600 | Form 4 |
| Iambic Therapeutics, Inc. Series B Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B-2 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B-3 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B-4 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Stock Option (right to buy), derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Convertible Promissory Notes, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-053477 | Dare Bioscience, Inc. | 2026-11-20 | ||
| Form 4 0001205903-26-000013 | Iambic Therapeutics, Inc. | 2026-10-19 | ||
| Form 4 0001205903-26-000011 | Iambic Therapeutics, Inc. | 2026-10-16 | ||
| Form 3 0001205903-26-000009 | Iambic Therapeutics, Inc. | 2026-10-14 |